The9 Limited (NASDAQ: NCTY), together with its subsidiaries, operates as an online game developer and operator in the People’s Republic of China...
BioSig Technologies Getting Traction with PURE EP ™ System, Could Move Following Listing on the NASDAQ
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company developing a proprietary biomedical signal processing technology designed to impro...
ATA Inc. Shares Soar on Sale of a Business Segment and Proposed Acquisition
ATA Inc. (NASDAQ: ATAI), through its subsidiaries, provides computer-based testing services in the People’s Republic of China. The company offer...
Rigel Pharmaceuticals, Traction from TAVALISSE Sales and Pipeline, Analysts Review and Target
Rigel Pharmaceuticals, Inc., (NASDAQ: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs t...
Marathon Patent Group Passes on Bitcoin Mining Merger, Developing its Own Mining Operation
Marathon Patent Group, Inc. (NASDAQ: MARA) is a digital asset technology company that mines cryptocurrencies, with a focus on the blockchain ecosystem...
Affimed Shares Leap on News of Genentech Deal, Analysts Review and Target
Affimed N.V. (NASDAQ: AFMD) is a clinical-stage biopharmaceutical company, focused on cancer immunotherapies. Its lead candidate is AFM13, a natural k...
RGS Energy, New POWERHOUSE™ Product with Projections, Analysts Review and Target
RGS Energy (NASDAQ: RGSE) is America’s Original Solar Company providing solar, storage and energy services whose mission is clean energy savings. The ...
Lithium Americas, New Financing and Project Updates, Analysts Target Price
Lithium Americas Corp. (NYSE: LAC) is developing the Caucharí-Olaroz, project, under construction in Jujuy, Argentina, and on the closing of a new tra...
Truett-Hurst Asset Sale for Cash, Analyst Report
Truett-Hurst, Inc. (NASDAQ: THST) is a holding company, and its sole asset is the controlling equity interest in H.D.D. LLC, an innovative super-premi...
Xenetic Biosciences Oncology Phase II Trial in Process
Xenetic Biosciences, Inc. (NASDAQ: XBIO), is a clinical-stage biopharmaceutical company, focused on the discovery, research, and development of next-g...